Sign In
Buy CRIS
$0.500
-0.0025 (-0.498%)
At Close: Jun 03, 2026
Curis, Inc. (CRIS) CEO Jim Dentzer on Q3 2020 Results - Earnings Call Transcript
07:25pm, Tuesday, 10'th Nov 2020
Curis, Inc. (CRIS) CEO Jim Dentzer on Q3 2020 Results - Earnings Call Transcript
Curis, Inc. (CRIS) CEO Jim Dentzer On Q3 2020 Results - Quick Version Earnings Call Transcript
05:53pm, Tuesday, 10'th Nov 2020
Curis, Inc. (CRIS) CEO Jim Dentzer On Q3 2020 Results - Quick Version Earnings Call Transcript
Curis: Q3 Earnings Insights
04:54pm, Tuesday, 10'th Nov 2020
Shares of Curis (NASDAQ:CRIS) fell 0.88% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 42.11% year over year to ($0.11), which beat the
LEXINGTON, Mass., Nov. 4, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced th
Curis to Present at H.C. Wainwright & Co. 6th Annual Israel Conference
08:01am, Wednesday, 04'th Nov 2020
LEXINGTON, Mass., Nov. 4, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced th
Oct 08, 2020 (The Expresswire) --
The Global "Hodgkin Lymphoma Treatment Market" is anticipated to rise at a considerable rate during the forecast period,...
Sep 22, 2020 (The Expresswire) --
Global “Follicular Lymphoma Treatment Market” Report discusses about the important developments impacting and increasing...
Curis (NASDAQ:CRIS) and Autolus Therapeutics (NASDAQ:AUTL) Critical Comparison
02:28am, Sunday, 20'th Sep 2020
Curis (NASDAQ:CRIS) and Autolus Therapeutics (NASDAQ:AUTL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their
Curis Reports Second Quarter 2020 Financial Results
08:01pm, Tuesday, 04'th Aug 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financial results for the second quarter ended
3 “Strong Buy” Penny Stocks That Could Go Boom
07:31pm, Tuesday, 04'th Aug 2020
The stock market has been holding up remarkably well, but why? Against the backdrop of weak second quarter earnings results, investors are piling in on the hope that a COVID-19 vaccine is coming, ther
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Curis to Release Second Quarter 2020 Financial Results and Hold Conference Call on August 4, 2020
12:00pm, Tuesday, 28'th Jul 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its second quarter
Curis (NASDAQ:CRIS) Stock Price Passes Above Two Hundred Day Moving Average of $1.15
04:08am, Thursday, 16'th Jul 2020
Curis, Inc. (NASDAQ:CRIS)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.15 and traded as high as $1.20. Curis share
Library Street Collective Auctions Will Fund Social Justice Causes
11:17am, Monday, 13'th Jul 2020
The Detroit gallery will offer a single artwork each week with 100% of proceeds going to the artist’s selected cause
